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Organochlorines and Prostate 
Cancer in Japan
No Link in Men without Occupational Exposures
Occupational exposure to organochlorine compounds during pesticide 
manufacturing or application has been associated with prostate cancer 
incidence. However, prostate cancer was not clearly associated with 
plasma levels of organochlorine compounds among Japanese men in 
the general population, according to results of a large-scale prospective 
study [EHP 118:659–665; Sawada et al.]. 
Organochlorines can act as endocrine disruptors. Studies in ani-
mals and humans have reported evidence of associations between 
significant environmental exposures and effects such as urogenital 
malformation in boys born to agricultural workers. Organochlorines 
were banned in the 1970s in Japan, where the current study was based. 
However, because these compounds persist in the environment, envi-
ronmental exposures may still be affecting human health. 
In a nested case–control study, the authors tracked the incidence 
of prostate cancer among 14,203 men aged 40–69 who were enrolled 
in a prospective study through the Japan Public Health Center. 
Participants responded to baseline health questionnaires and provided 
blood samples between 1990 and 1995; they were followed through 
2005. The authors identified 201 participants who were diagnosed 
with prostate cancer during the period of the study, each of whom 
was matched with two controls from the study cohort. The baseline 
blood samples from these 603 men were analyzed for poly-
chlorinated biphenyls (PCBs) and several organochlorine 
pesticides. 
The authors found no statistically significant associa-
tions between blood levels of any organochlorine and pros-
tate cancer. Contrary to expectations, men who developed 
cancer had lower blood levels of the pesticides hexachloro-
benzene and β-hexachlorocyclohexane than men who did 
not develop cancer, though these inverse associations were 
not statistically significant. 
Strengths of the study include the large number of par-
ticipants and the use of biological samples collected many 
years before diagnosis. However, the authors acknowledge 
the small number of cases of prostate cancer may have lim-
ited their ability to detect associations with organochlorine 
exposures. Moreover, the length of followup may have been 
insufficient to fully detect incidence of prostate cancer, 
which is generally slow to develop. 
Kris S. Freeman has written for Encarta encyclopedia, NIH, ABCNews.com, and 
the National Park Service. Her research on the credibility of online health informa-
tion appeared in the June 2009 IEEE Transactions on Professional Communication.
An Inkling of Suspicion
Prenatal Exposure to PBDEs and 
Neurodevelopmental Impairment
A longitudinal cohort study of more than 150 U.S. children con-
ducted over 7 years associates prenatal exposure to higher concentra-
tions of polybrominated diphenyl ether (PBDE) flame retardants 
with lower scores on tests of neurodevelopment [EHP 118:712–719; 
Herbstman et al.]. This is the second recent epidemiologic study to 
link PBDEs with evidence of adverse effects on brain development, 
although differences in methodology between this and the other 
study [EHP 117:1953–1958; Roze et al.] make direct comparisons 
difficult.
PBDE flame retardants have been used for decades in a wide 
variety of goods, including automobile and airplane components, 
electronics, and home and office furnishings. The toxicologic evidence 
linking PBDEs to adverse health effects led the European Union 
to use the precautionary principle as the basis for banning all three 
PBDE formulations (penta, octa, and deca). In the United States, 
manufacturers voluntarily discontinued the penta and octa formula-
tions in 2004 and have agreed to phase out deca by the end of 2012.
The mothers of the children in the current study were pregnant at 
the time of the World Trade Center (WTC) attacks in 2001 and gave 
birth at a hospital within 2 miles of the WTC site. The women were 
recruited for a study on the effects of exposure to compounds in dust 
from the decimated towers. PBDEs were measured in the cord blood 
of 210 infants, and 152 of these children later participated in at least 
one round of neurodevelop  mental testing conducted at 1, 2, 3, 4, and 
6 years of age.
The children with higher levels of exposures consistently had, on 
average, lower developmental scores at each time point compared with 
less-exposed children; the association was particularly evident at age 
4 years. The researchers were not able to evaluate associations with 
developmental delay because few children had developmental scores low 
enough to meet the criterion for this outcome. However, in many cases 
average test scores in children with exposures in the highest 20% were 
5–11 points lower than average scores for less-exposed children. 
Although some evidence suggests the PBDE exposure seen in the 
children could be related to the WTC attack, the authors say “it is 
certain” that sources other than the WTC contributed to the PBDE 
levels in the infants’ cord blood. Because the levels observed in these 
children were similar to those reported in other U.S. populations, the 
new research suggests the observed effects could be widespread.
According to the authors, these findings are consistent with reports of 
hyperactivity and learning and memory deficits in experiments with mice 
exposed neonatally to PBDEs. Other work, most recently a laboratory 
study using human cells [EHP 118:572–578; Schreiber et al.], suggests 
PBDEs may interfere with thyroid hormones critical for normal brain 
development. The authors point out that additional studies exploring 
associations between PBDE exposure and developmental effects are 
under way. In the meantime, they say identifying opportunities to reduce 
people’s exposure to these compounds should be a priority.
Kellyn S. Betts has written about environmental contaminants, hazards, and technology for 
solving environmental problems for publications including EHP and Environmental Science & 
Technology for more than a dozen years.Pregnant Pause
Does Maternal PBDE Exposure Extend  
Time to Pregnancy?
Animal studies indicate polybrominated diphenyl ethers (PBDEs) 
are endocrine disruptors, potentially affecting the role of thyroid 
hormones in regulating the reproductive cycle and fertility. The 
compounds also have been associated with delayed puberty and 
altered estradiol levels in female animals. Very little is known about 
the potential effects of PBDEs on human reproductive health, 
though, and a new study is the first to characterize a specific 
concern—a relationship between PBDE blood concentrations and 
a delay in achieving pregnancy [EHP 118:699–704; Harley et al.].
PBDEs are used as flame retardants in furniture, carpeting, 
textiles, electronics, and plastics. Commercial mix-
tures of PBDEs contain a variety of congeners, or 
chemical variations. Data collected by the Centers 
for Disease Control and Prevention suggest 97% of 
Americans may have detectable levels of PBDEs in 
their blood. 
The current study included 223 pregnant women 
enrolled in the Center for the Health Assessment of 
Mothers and Children of Salinas (CHAMACOS), 
a longitudinal birth cohort study focused on envi-
ronmental exposures and reproductive health in 
California’s Salinas Valley. Upon enrollment, the 
women reported their reproductive history, previous 
use of contraception and fertility medication, whether 
the pregnancy was planned, and how long it took to 
become pregnant after stopping contraception.  
Blood samples collected around 26 weeks of 
pregnancy were analyzed for 10 PBDE congeners. 
Statistical analyses focused on those most commonly 
found: BDE-47, BDE-99, BDE-100, and BDE-153. 
BDE-100 and BDE-153 were the most strongly associ-
ated with longer time to pregnancy. For each month, 
the likelihood of becoming pregnant was 40% or 50% lower with 
a 10-fold increase in concentration of BDE-100 or -153, respec-
tively. With a 10-fold increase in the total of all 4 congeners, there 
was a 30% decrease in the odds of pregnancy each month.
The study relied on self-reported time to pregnancy, which 
is subject to a number of biases. In addition, the study’s find-
ings are limited to 4 PBDE congeners and may not extend to a 
broader population. Consequently, further research incorporating 
more congeners and a more representative population is needed. 
However, given the likelihood of PBDE exposure in the general 
population, even a small effect of these chemicals on fertility may 
affect a large number of individuals. 
Julia R. Barrett, MS, ELS, a Madison, WI–based science writer and editor, has written for EHP 
since 1996. She is a member of the National Association of Science Writers and the Board of 
Editors in the Life Sciences.
Cancer Collusion?
Dietary Fat May Modify Dioxin-Induced 
Mammary Cancer Risk
Some human and animal studies have linked early-life exposure to the 
endocrine-disrupting chemical 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) with an increased susceptibility to breast cancer. Dietary fat 
has been posited as another potential risk factor for breast cancer, possi-
bly acting through the estrogen pathway. A new animal study suggests 
a high-fat diet may alter estrogen metabolism, thereby modifying the 
effects of maternal exposure to TCDD and increasing mammary can-
cer risk in the next generation [EHP 118:596–601; La Merrill et al.].
One group of pregnant female FVB/NJ mice (a TCDD-
responsive mouse strain) received an olive oil/toluene blend with 
TCDD; another received an equivalent volume of olive oil/toluene 
without TCDD. Their female offspring were randomly assigned to 
either a low-fat or high-fat diet and exposed to the carcinogen 7,12-
dimethyl-benz[a]anthracene (DMBA) at days 35, 49, and 63 after 
birth in order to initiate mammary tumors. A second cohort of female 
offspring was treated identically until either day 35 or 49, when 
morphologic and molecular analyses of their mammary glands were 
performed.
Maternal TCDD exposure was associated with a doubling of 
mammary tumor incidence only in offspring fed the high-fat diet. 
In contrast, no mammary tumors arose in mice exposed to TCDD 
in utero and fed the low-fat diet. Whereas one-third of TCDD-
unexposed litters fed a high-fat diet had DMBA-induced mammary 
lesions, every litter exposed to both TCDD and a high-fat diet devel-
oped mammary lesions. 
Previous animal studies had shown that prenatal exposure to 
TCDD alters mammary gland differentiation and increases suscep-
tibility to mammary cancer. However, this is the first to show that 
TCDD may interact with a high-fat diet during pregnancy and early 
life. The researchers propose that a high-fat diet may boost sensitivity 
to maternal TCDD exposure by altering estrogen metabolism. 
The new findings highlight a possible mechanism that may 
explain epidemiologic data separately linking early-life TCDD expo-
sure and high-fat diets to increased breast cancer risk in humans. In 
the present study, TCDD exposure in utero combined with a high-
fat diet was also associated with increased expression of Cyp1b1 and 
decreased expression of Comt in mammary tissue. Human studies 
have suggested that diminished COMT expression and increased 
CYP1B1 expression are associated with increased risk of breast cancer 
and other estrogen-responsive cancers, perhaps by increasing levels of 
estrogen metabolites that can contribute to carcinogenesis by damag-
ing DNA. They also note that obesity may affect breast cancer risk 
because TCDD persists in adipose tissue, including that in the breast.
M. Nathaniel Mead, a science writer living in Durham, NC, has written for EHP since 2002.
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